Abiomed partners with Fenway Park

Abiomed (NSDQ:ABMD) said today it entered into a corporate partnership with Boston’s Fenway Park, and will bring its Impella mobile learning lab to the stadium tomorrow.

The lab will be parked at Fenway so individuals in healthcare and medical fields can learn about its Impella heart pump, which the Danvers, Mass.-based company says is the world’s smallest.

“We are delighted to form a partnership with this leader in the medical technology industry. Abiomed is helping to recover hearts and save lives with its innovative technology and helping the Massachusetts economy by expanding its headquarters locally.  We look forward to playing host to its mobile learning lab at Fenway Park on August 12,” Red Sox COO Sam Kennedy said in a press release.

The mobile learning lab is designed to enable individuals to learn about protected percutaneous coronary intervention procedures, such as angioplasty and stenting, the company said.

“As a Massachusetts-based company since 1981, we are passionate Red Sox fans and are excited and honored to enter into this partnership with Fenway Park. We have reached an inflection point in our Company and we’re pleased to bring the Mobile Learning Lab to Boston – one of the leading healthcare innovation centers in the entire world,” Michael R. Minogue, Chairman, President and Chief Executive Officer of Abiomed.  “

The post Abiomed partners with Fenway Park appeared first on MassDevice.

from MassDevice http://ift.tt/1IDrdyv